Printer Friendly
The Free Library
14,652,131 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

GL & V acquires worldwide license.


GL & V ACQUIRES WORLDWIDE LICENSE. Groupe Laperriere & Verreault Inc. (GL & V), Trois-Rivieres, Canada Canada (kăn`ədə), independent nation (2001 pop. 30,007,094), 3,851,787 sq mi (9,976,128 sq km), N North America. Canada occupies all of North America N of the United States (and E of Alaska) except for Greenland and the French islands of , has signed an agreement with BTF BTF Back to the Future (movie)
BTF Berkshire Theatre Festival (Stockbridge, MA)
BTF Blessthefall (band)
BTF Bidirectional Texture Function
 for the exclusive worldwide license to market and sell BTF Headbox and Dilution Dilution

A reduction in earnings per share of common stock that occurs through the issuance of additional shares or the conversion of convertible securities.

Notes:
Adding to the number of shares outstanding reduces the value of holdings of existing shareholders.
 Profiling Technology. This agreement will now allow GL & V to develop a focused marketing plan with all of its sales forces, licensees, agents and strategic partners worldwide.
COPYRIGHT 2004 Paper Industry Management Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Supplier News
Publication:Solutions - for People, Processes and Paper
Date:Aug 1, 2004
Words:59
Previous Article:Fisher International opens new office in Finland.(Supplier News)
Next Article:IBM increases forest industry ROCE.(Supplier News)



Related Articles
FUJITSU AND GLOBAL LOCATE INTRO GL-16000 IC FOR WIRELESS GPS APPS.
Letters to the editor.(Letters)
New contracts worth more than US $10 million for GL&V.(Supplier News)
GL&V.(Supplier News)
GL&V USA acquires Cameron Machine.(Supplier News)
ROCHE/GLYCART TO DISCOVER NEW THERAPEUTIC ANTIBODIES.
Karen the editor's page.(Editorial)
French say 'oui' to Mad Ave growth.(GL Consultants Inc. is doubling its office space)(Brief Article)
Astellas Pharma, Theravance to Enter into Licensing Agreement for Investigational Antibiotic Telavancin.
GL & V acquires KanEng.(SUPPLIER NEWS)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles